Live
- Comprehensive education employees protest for pay scale implementation
- Bengal school job case: SC orders Partha Chatterjee's release on bail by Feb 1
- YSRCP stages protests on farmers' issues across AP
- Massive Drug Seizure in Sangareddy: Rs. 100 Crore Worth Drugs Confiscated
- Andrei Filatov Accuses Ding Liren of Deliberate Loss to D. Gukesh in World Chess Final
- BPSC Prelims Exam in Bihar today; 4.80 lakh candidates to appear
- 24 cops transferred for involvement in sand smuggling
- Industry must skill, provide job opportunities to disabled: Piyush Goyal
- Vishwak Sen's Mechanic Rocky to Stream on This OTT Platform on This Day
- Sensex, Nifty fall more than 1 pc as global risks weigh on market sentiment
Coronavirus Vaccine: Sampled 1125 people for human trials in Delhi AIIMS, results may come in 2-3 months
Coronavirus Vaccine
Highlights
Human trial of the first coronavirus vaccine made in India is going to start in AIIMS, Delhi.
New Delhi: Human trial of the first coronavirus vaccine made in India is going to start in AIIMS, Delhi. A total of 1125 samples have been taken for the trial, out of which 375 healthy people will be tried in the first phase. This information was given by Delhi-based AIIMS director Randeep Guleria.
Dr Randeep Guleria said that in the first phase, vaccine trials will be done on healthy people aged 18-55 years who have no co-morbidity. At the same time, in the second phase, 750 people aged 12-56 will be tried. He told that its results can come in 2-3 months.
Next Story
ADVERTISEMENT
